Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $84.92 USD
Change Today -0.08 / -0.09%
Volume 1.4M
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

endo international plc (ENDP) Snapshot

Open
$85.06
Previous Close
$85.00
Day High
$86.05
Day Low
$84.56
52 Week High
04/16/15 - $96.58
52 Week Low
10/15/14 - $57.14
Market Cap
15.2B
Average Volume 10 Days
3.0M
EPS TTM
$2.88
Shares Outstanding
178.7M
EX-Date
--
P/E TM
29.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for ENDO INTERNATIONAL PLC (ENDP)

endo international plc (ENDP) Details

Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, including Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain management, urology, CNS disorders, immunosuppression, oncology, women’s health, hypertension, generic lidocaine patch, and other markets. The Devices segment provides various medical devices comprising AMS 800 artificial urinary sphincters, AMS 700 MS series, Monarc subfascial hammock products, Elevate anterior and posterior pelvic floor repair systems, and GreenLight XPS laser systems in the areas of men’s and women’s pelvic health. The International Pharmaceuticals segment offers Dexedrine, Tridural, Metadol, Trandate, Pennsaid, and Plan B products in therapeutic areas, including attention deficit hyperactivity disorder, pain, urology, and allergy. It sells its branded pharmaceuticals and generics directly to large pharmacy chains; and through wholesale drug distributors to pharmacies, hospitals, governmental agencies, and physicians. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

5,062 Employees
Last Reported Date: 03/2/15
Founded in 1920

endo international plc (ENDP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.1M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $835.8K
President of American Medical Systems, Inc
Total Annual Compensation: $567.8K
Special Advisor to the Chief Executive Office...
Total Annual Compensation: $660.3K
Compensation as of Fiscal Year 2014.

endo international plc (ENDP) Key Developments

Endo International plc Appoints Paul Campanelli to Lead Generics Business and Join Executive Leadership Team

Endo International plc and Par Pharmaceutical Holdings Inc. announced that they have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. Par CEO Paul Campanelli to join Endo to lead generics business and join executive leadership team.

Endo International plc, Par Pharmaceutical Holdings, Inc. - M&A Call

To discuss the acquisition of Par Pharmaceutical

Endo International Seeks Acquisitions

Endo International plc (NasdaqGS:ENDP) will consider acquisitions. Endo said it is seeking a capital structure that will allow for more acquisitions in the future.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENDP:US $84.92 USD -0.08

ENDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.133.00 CHF -1.40
CR Bard Inc $171.95 USD -0.43
Edwards Lifesciences Corp $130.88 USD -0.94
Mallinckrodt PLC $127.18 USD -1.63
UCB SA €64.54 EUR +2.00
View Industry Companies
 

Industry Analysis

ENDP

Industry Average

Valuation ENDP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDO INTERNATIONAL PLC, please visit www.endo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.